Cormorant Global Healthcare Master Fund, LP - Insider Non-Derivative Transactions at Ambrx Biopharma, Inc. (AMAM) - (SEC)
Updated on December 12, 2024.
According to recent SEC insider information filed on Oct 23, 2023, Cormorant Global Healthcare Master Fund, LP's relationship to Ambrx Biopharma, Inc. (AMAM) is TenPercentOwner, and currently has 69,465,823 shares of Ordinary Shares, and 11,231,000 shares of Common Stock.
The the number of shares owned, and the table shows the recent insider transactions.
You can see similar information for other AMAM insiders.
Data Source: SEC.
Cormorant Global Healthcare Master Fund, LP - Insider Non-Derivative Transactions of AMAM Ordinary Shares
Cormorant Global Healthcare Master Fund, LP - Insider Non-Derivative Transactions at AMAM
Items per page:
0 of 0
| Date | Transaction | No. of Shares | Price Per Share | Shares Owned After Transactions |
|---|---|---|---|---|
| Oct 24, 2023 | P -- (Common Stock) | 1307311 | 6.99 | 11231000 |
| Sep 19, 2023 | P -- (Ordinary Shares) | 751233 | 9.24 | 69465823 |
| Sep 16, 2023 | P -- (Ordinary Shares) | 1401505 | 9.05 | 68714590 |